Know Cancer

or
forgot password

Molecular Epidemiology of Acute Myelogenous Leukemia


N/A
18 Years
N/A
Open (Enrolling)
Both
Leukemia

Thank you

Trial Information

Molecular Epidemiology of Acute Myelogenous Leukemia


INFORMED CONSENTS FOR AML PATIENTS:

For this study, you will be asked to complete a personal interview. During the interview,
you will be asked questions about your demographics (age, sex, etc.), any chemicals you may
have been exposed to, your medical history, family history of cancer, your diet, and your
smoking and alcohol use histories. It should take around 50 minutes to complete the
interview.

You will also have around 1 tablespoon of blood drawn for special tests. These tests will
look for any biologic factors associated with AML.

The interview and the blood draw may be done during a regularly scheduled visit to M. D.
Anderson, or may be scheduled at the time and place of your convenience.

You may be contacted at home by phone so that researchers can collect information about any
changes in your health status.

THIS IS AN INVESTIGATIONAL STUDY. Up to 1,200 participants will take part in this study.

INFORMED CONSENT FOR CONTROL SUBJECTS:

For this study, you will be asked to complete a personal interview. During the interview,
you will be asked questions about your demographics (age, sex, etc.), any chemicals you may
have been exposed to, your medical history, family history of cancer, your diet, and your
smoking and alcohol use histories. It should take around 50 minutes to complete the
interview.

You will also have around 1 tablespoon of blood drawn for special tests. These tests will
look for any biologic factors associated with AML. The interview and blood draw will be
scheduled at the time and place of your convenience.

THIS IS AN INVESTIGATIONAL STUDY. Up to 1,200 participants will take part in this study.


Inclusion Criteria:



1. A histologically confirmed diagnosis of AML (patients only)

2. Aged 18 or older

3. Resident of Texas

4. Willing and able to provide written informed consent and authorization

5. Willing to donate 10mL of blood and complete a personal interview

Exclusion Criteria:

1. Under 18 years of age

2. History of invasive cancer, excluding non-melanoma skin cancer (controls only)

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

Identify biologic and lifestyle factors that may increase a person's risk of developing acute myelogenous leukemia.

Outcome Time Frame:

8 Years

Safety Issue:

No

Principal Investigator

Sara Strom, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D. Anderson Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

ID03-0250

NCT ID:

NCT00502983

Start Date:

September 2003

Completion Date:

Related Keywords:

  • Leukemia
  • Acute Myelogenous Leukemia
  • Epidemiology
  • Leukemia
  • Healthy Control
  • Lifestyle Factors
  • Genetic Susceptibility
  • Interview
  • AML
  • Leukemia
  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid

Name

Location

UT MD Anderson Cancer CenterHouston, Texas  77030